Since antiretroviral therapy requires a lifelong<unk>  regimen, research to find more permanent cures for HIV infection is currently underway. It is possible to synthesize<unk><unk>  nucleotides with<unk><unk>  components that selectively (almost selectively) bind to specific portions of DNA. Conceptually, targeting and editing could focus on host cellular co-receptors for HIV or on proviral HIV DNA.
Zinc finger nuclease treatment of HIV
Discovery and development of non-nucleoside reverse-transcriptase inhibitors
Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors
Innate resistance to HIV
HIV vaccine development
Cancer vaccine targeting CD4+ T cells
Zika virus vaccine
T cell receptor T cell therapy